# FDA recall D-0388-2026

> **ANTHONY TRINH, 123Herbals LLC** · Class I · drug recall initiated 2025-10-20.

## Product

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

## Reason for recall

Marketed Without an Approved NDA/ANDA: FDA analysis  revealed the presence of undeclared meloxicam.

## Distribution

USA nationwide

## Key facts

- **Recall number:** D-0388-2026
- **Recalling firm:** ANTHONY TRINH, 123Herbals LLC
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-10-20
- **Report date:** 2026-03-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rosemead, CA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0388-2026

## Citation

> AI Analytics. FDA recall D-0388-2026. Retrieved 2026-07-15 from https://api.ai-analytics.org/recall/D-0388-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*